Doximity (NASDAQ:DOCS) Given New $80.00 Price Target at Robert W. Baird

Doximity (NASDAQ:DOCSFree Report) had its target price upped by Robert W. Baird from $75.00 to $80.00 in a report released on Thursday morning,Benzinga reports. Robert W. Baird currently has an outperform rating on the stock.

A number of other research firms have also recently issued reports on DOCS. BTIG Research raised shares of Doximity from a “neutral” rating to a “buy” rating and set a $80.00 price target for the company in a report on Monday, June 2nd. Evercore ISI raised shares of Doximity from an “in-line” rating to an “outperform” rating and raised their price target for the stock from $50.00 to $70.00 in a report on Wednesday, July 9th. Wells Fargo & Company raised their price target on shares of Doximity from $55.00 to $62.00 and gave the stock an “equal weight” rating in a report on Monday, August 4th. Piper Sandler raised their price target on shares of Doximity from $65.00 to $69.00 and gave the stock an “overweight” rating in a report on Monday, August 11th. Finally, Mizuho decreased their price target on shares of Doximity from $65.00 to $60.00 and set a “neutral” rating for the company in a report on Friday, May 16th. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and eleven have given a Hold rating to the company’s stock. According to MarketBeat, Doximity has a consensus rating of “Moderate Buy” and a consensus price target of $67.00.

Read Our Latest Stock Report on DOCS

Doximity Stock Performance

NASDAQ DOCS opened at $70.26 on Thursday. The firm’s 50 day moving average price is $63.42 and its 200-day moving average price is $59.93. Doximity has a 52-week low of $36.78 and a 52-week high of $85.21. The company has a market cap of $13.16 billion, a PE ratio of 70.26, a P/E/G ratio of 4.10 and a beta of 1.37.

Doximity (NASDAQ:DOCSGet Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same quarter in the previous year, the business earned $0.28 earnings per share. Doximity’s quarterly revenue was up 15.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, analysts forecast that Doximity will post 0.99 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Regina M. Benjamin sold 5,000 shares of the firm’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $63.00, for a total value of $315,000.00. Following the transaction, the director directly owned 16,618 shares of the company’s stock, valued at approximately $1,046,934. This trade represents a 23.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Timothy S. Cabral sold 10,000 shares of Doximity stock in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00. Following the transaction, the director directly owned 6,360 shares in the company, valued at $381,600. This trade represents a 61.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 32,000 shares of company stock worth $1,929,380 over the last 90 days. 31.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Doximity

A number of institutional investors and hedge funds have recently made changes to their positions in DOCS. Hantz Financial Services Inc. raised its stake in shares of Doximity by 148.9% in the 2nd quarter. Hantz Financial Services Inc. now owns 453 shares of the company’s stock valued at $28,000 after acquiring an additional 271 shares during the period. VSM Wealth Advisory LLC purchased a new stake in shares of Doximity in the 1st quarter valued at approximately $29,000. Allworth Financial LP raised its stake in shares of Doximity by 104.0% in the 1st quarter. Allworth Financial LP now owns 563 shares of the company’s stock valued at $32,000 after acquiring an additional 287 shares during the period. National Bank of Canada FI purchased a new stake in shares of Doximity in the 1st quarter valued at approximately $33,000. Finally, Spire Wealth Management raised its stake in shares of Doximity by 73.2% in the 1st quarter. Spire Wealth Management now owns 615 shares of the company’s stock valued at $36,000 after acquiring an additional 260 shares during the period. 87.19% of the stock is owned by hedge funds and other institutional investors.

Doximity Company Profile

(Get Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Read More

Analyst Recommendations for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.